Synthetic polyamines: An overview of their multiple biological activities

Amino Acids

Volumn 38, Issue 2, 2010, Pages 383-392

  Minarini, Anna ^a   Milelli, Andrea ^a   Tumiatti, Vincenzo ^a   Rosini, Michela ^a   Bolognesi, Maria Laura ^a   Melchiorre, Carlo ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Memoquin; Methoctramine; MTDLs; Polyamines; Universal template

Indexed keywords

ACETYLCHOLINESTERASE; BENEXTRAMINE; CAPROCTAMINE; CHOLINESTERASE INHIBITOR; METHOCTRAMINE; MUSCARINIC RECEPTOR; NEUROTRANSMITTER RECEPTOR; NICOTINIC RECEPTOR; POLYAMINE DERIVATIVE; UNCLASSIFIED DRUG; ENZYME; POLYAMINE;

ALZHEIMER DISEASE; BINDING AFFINITY; BIOLOGICAL ACTIVITY; CONFERENCE PAPER; CYTOTOXICITY; DRUG DESIGN; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG TARGETING; LIGAND BINDING; MOLECULARLY TARGETED THERAPY; PATHOGENESIS; PRIORITY JOURNAL; RECEPTOR BINDING; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; HUMAN; KINETICS; METABOLISM; PROTEIN BINDING; REVIEW; SYNTHESIS;

ANIMALS; ENZYMES; HUMANS; KINETICS; MOLECULAR STRUCTURE; POLYAMINES; PROTEIN BINDING; RECEPTORS, NEUROTRANSMITTER;

EID: 77953055003     PISSN: 09394451     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00726-009-0430-9     Document Type: Conference Paper

References (47)

1. Andersen TF, Tikhonov DB, Bolcho U, Bolshakov K, Nelson JK, Pluteanu F, Mellor IR, Egebjerg J, Stromgaard K (2006) Uncompetitive antagonism of AMPA receptors: mechanistic insights from studies of polyamine toxin derivatives. J Med Chem 49 (18):5414-5423
2. Bachrach U (2005) Naturally occurring polyamines: interaction with macromolecules. Curr Protein Pept Sci 6 (6):559-566
3. Barlow RB, Kitchen R (1982) The actions of some esters of 4-hydroxyquinuclidine on guinea-pig ileum, atria and rat fundus strip. Br J Pharmacol 77 (3):549-557
4. Bartolini M, Bertucci C, Cavrini V, Andrisano V (2003) Beta-amyloid aggregation induced by human acetylcholinesterase: inhibition studies. Biochem Pharmacol 65 (3):407-416
5. Benfey BG, Yong MS, Belleau B, Melchiorre C (1979) Cardiac muscarinic blocking and atropinic blocking effects of a tetramine disulfide and alpha-adrenoceptor blocking activity. Can J Physiol Pharmacol 57 (1):41-47
6. Benfey BG, Belleau B, Brasili L, Giannella M, Melchiorre C (1980) Irreversible alpha adrenoceptor blocking effects and reversible muscarinic blocking and nicotinic blocking effects of tetramine disulfides on the heart. Can J Physiol Pharmacol 58 (12):1477-1483
7. Bixel MG, Weise C, Bolognesi ML, Rosini M, Brierly MJ, Mellor IR, Usherwood PN, Melchiorre C, Hucho F (2001) Location of the polyamine binding site in the vestibule of the nicotinic acetylcholine receptor ion channel. J Biol Chem 276 (9):6151-6160
8. Bolognesi ML, Bixel MG, Marucci G, Bartolini M, Krauss M, Angeli P, Antonello A, Rosini M, Tumiatti V, Hucho F, Melchiorre C (2002) Structure-activity relationships of methoctramine-related polyamines as muscular nicotinic receptor noncompetitive antagonists. 3. Effect of inserting the tetraamine backbone into a macrocyclic structure. J Med Chem 45 (15):3286-3295
9. Bolognesi ML, Banzi R, Bartolini M, Cavalli A, Tarozzi A, Andrisano V, Minarini A, Rosini M, Tumiatti V, Bergamini C, Fato R, Lenaz G, Hrelia P, Cattaneo A, Recanatini M, Melchiorre C (2007) Novel class of quinone-bearing polyamines as multi-target-directed ligands to combat Alzheimer's disease. J Med Chem 50 (20):4882-4897
10. Bonner TI (1989) The molecular basis of muscarinic receptor diversity. Trends Neurosc 12 (4):148-151
11. Casero RA Jr, Marton LJ (2007) Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases. Nat Rev Drug Discov 6 (5):373-390
12. Casero RA, Woster PM (2009) Recent advances in the development of polyamine analogues as antitumor agents. J Med Chem 52 (15):4551-4573
13. Cavalli A, Bolognesi ML, Minarini A, Rosini M, Tumiatti V, Recanatini M, Melchiorre C (2008) Multi-target-directed ligands to combat neurodegenerative diseases. J Med Chem 51 (3):347-372
14. Eberlein WG, Engel W, Mihm G, Rudolf K, Wetzel B, Entzeroth M, Mayer N, Doods HN (1989) Structure-activity relationships and pharmacological profile of selective tricyclic antimuscarinics. Trends Pharmacol Sci Suppl IV: 50-54
15. Eldefrawi AT, Eldefrawi ME, Konno K, Mansour NA, Nakanishi K, Oltz E, Usherwood PN (1988) Structure and synthesis of a potent glutamate receptor antagonist in wasp venom. Proc Natl Acad Sci USA 85 (13):4910-4913
16. Fisher A (2008) Cholinergic treatments with emphasis on m1 muscarinic agonists as potential disease-modifying agents for Alzheimer's disease. Neurotherapeutics 5 (3):433-442
17. Gerner EW, Meyskens FL Jr (2004) Polyamines and cancer: old molecules, new understanding. Nat Rev Cancer 4 (10):781-792
18. Hucho F, Hilgenfeld R (1989) The selectivity filter of a ligand-gated ion channel. The helix-M2 model of the ion channel of the nicotinic acetylcholine receptor. FEBS Lett 257 (1):17-23
19. Inestrosa NC, Alvarez A, Perez CA, Moreno RD, Vicente M, Linker C, Casanueva OI, Soto C, Garrido J (1996) Acetylcholinesterase accelerates assembly of amyloid-beta-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme. Neuron 16 (4):881-891
20. Kostenis E, Zeng FY, Wess J (1998) Structure-function analysis of muscarinic acetylcholine receptors. J Phys 92 (3-4): 265-268
21. Melchiorre C (1988) Polymethylene tetramines: a new generation of selective muscarinic antagonists. Trends Pharmacol Sci 9 (6):216-220
22. Melchiorre C (1990) Polymethylene tetraamines: a novel class of cardioselective M2-antagonists. Med Res Rev 10 (3):327-349
23. Melchiorre C, Cassinelli A, Quaglia W (1987) Differential blockade of muscarinic receptor subtypes by polymethylene tetraamines. Novel class of selective antagonists of cardiac M-2 muscarinic receptors. J Med Chem 30 (1):201-204
24. Melchiorre C, Minarini A, Angeli P, Giardina D, Gulini U, Quaglia W (1989) Polymethylene tetraamines as muscarinic receptor probes. Trends Pharmacol Sci Suppl IV: 55-59
25. Melchiorre C, Bolognesi ML, Chiarini A, Minarini A, Spampinato S (1993) Synthesis and biological activity of some methoctramine-related tetraamines bearing a 11-acetyl-5, 11-dihydro-6H-pyr-ido[2, 3-b][1, 4]-benzodiazepin-6-one moiety as antimuscarinics: a second generation of highly selective M2 muscarinic receptor antagonists. J Med Chem 36 (23):3734-3737
26. Melchiorre C, Minarini A, Spampinato S, Tumiatti V (1995) Design, synthesis and biological-activity of some tetraamines related to methoctramine and 4-DAMP. Bioorg Med Chem Lett 5 (8):785-790
27. Melchiorre C, Andrisano V, Bolognesi ML, Budriesi R, Cavalli A, Cavrini V, Rosini M, Tumiatti V, Recanatini M (1998) Acetylcholinesterase noncovalent inhibitors based on a poly-amine backbone for potential use against Alzheimer's disease. J Med Chem 41 (22):4186-4189
28. Melchiorre C, Antonello A, Banzi R, Bolognesi ML, Minarini A, Rosini M, Tumiatti V (2003) Polymethylene tetraamine backbone as template for the development of biologically active polyamines. Med Res Rev 23 (2):200-233
29. Mellor IR, Ogilvie J, Pluteanu F, Clothier RH, Parker TL, Rosini M, Minarini A, Tumiatti V, Melchiorre C (2004) Methoctramine analogues inhibit responses to capsaicin and protons in rat dorsal root ganglion neurons. Eur J Pharm 505 (1-3): 37-50
30. Minarini A, Bolognesi ML, Budriesi R, Canossa M, Chiarini A, Cacciaguerra S (1994) Design, synthesis, and biological activity of methoctramine-related tetraamines bearing an 11-acetyl-5, 11-dihydro-6H-pyrido[2, 3-b][1, 4] benzodiazepin-6-one moiety: structural requirements for optimum occupancy of muscarinic receptor subtypes as revealed by symmetrical and unsymmetrical polyamines. J Med Chem 37 (20):3363-3372
31. Nakanishi K, Huang X, Jiang H, Liu Y, Fang K, Huang D, Choi SK, Katz E, Eldefrawi M (1997) Structure-binding relation of philanthotoxins from nicotinic acetylcholine receptor binding assay. Bioorg Med Chem 5 (10):1969-1988
32. Recanatini M, Tumiatti V, Budriesi R, Chiarini A, Sabatino P, Bolognesi ML, Melchiorre C (1995) Synthesis, muscarinic blocking activity and molecular modeling studies of 4-DAMP-related compounds. Bioorg Med Chem 3 (3):267-277
33. Rosini M, Budriesi R, Bixel MG, Bolognesi ML, Chiarini A, Hucho F, Krogsgaard-Larsen P, Mellor IR, Minarini A, Tumiatti V, Usherwood PN, Melchiorre C (1999) Design, synthesis, and biological evaluation of symmetrically and unsymmetrically substituted methoctramine-related polyamines as muscular nicotinic receptor noncompetitive antagonists. J Med Chem 42 (25):5212-5223
34. Rosini M, Bixel MG, Marucci G, Budriesi R, Krauss M, Bolognesi ML, Minarini A, Tumiatti V, Hucho F, Melchiorre C (2002) Structure-activity relationships of methoctramine-related poly-amines as muscular nicotinic receptor noncompetitive antagonists. 2. Role of polymethylene chain lengths separating amine functions and of substituents on the terminal nitrogen atoms. J Med Chem 45 (9):1860-1878
35. Rozental R, Scoble GT, Albuquerque EX, Idriss M, Sherby S, Sattelle DB, Nakanishi K, Konno K, Eldefrawi AT, Eldefrawi ME (1989) Allosteric inhibition of nicotinic acetylcholine receptors of vertebrates and insects by philanthotoxin. J Pharmacol Exp Ther 249 (1):123-130
36. Salloway S, Mintzer J, Weiner MF, Cummings JL (2008) Disease-modifying therapies in Alzheimer's disease. Alzheimers Dement 4 (2):65-79
37. Stefanelli C, Bonavita F, Stanic I, Mignani M, Facchini A, Pignatti C, Flamigni F, Caldarera CM (1998) Spermine causes caspase activation in leukaemia cells. FEBS Lett 437 (3):233-236
38. Stromgaard K, Mellor I (2004) AMPA receptor ligands: synthetic and pharmacological studies of polyamines and polyamine toxins. Med Res Rev 24 (5):589-620
39. Stromgaard K, Jensen LS, Vogensen SB (2005) Polyamine toxins: development of selective ligands for ionotropic receptors. Toxicon 45 (3):249-254
40. Stys PK, Lipton SA (2007) White matter NMDA receptors: an unexpected new therapeutic target? Trends Pharmacol Sci 28 (11):561-566
41. Thomas T, Thomas TJ (2001) Polyamines in cell growth and cell death: molecular mechanisms and therapeutic applications. Cell Mol Life Sci 58 (2):244-258
42. Tumiatti V, Rosini M, Bartolini M, Cavalli A, Marucci G, Andrisano V, Angeli P, Banzi R, Minarini A, Recanatini M, Melchiorre C (2003) Structure-activity relationships of acetylcholinesterase noncovalent inhibitors based on a polyamine backbone. 2. Role of the substituents on the phenyl ring and nitrogen atoms of caproctamine. J Med Chem 46 (6):954-966
43. Tumiatti V, Andrisano V, Banzi R, Bartolini M, Minarini A, Rosini M, Melchiorre C (2004) Structure-activity relationships of acetylcholinesterase noncovalent inhibitors based on a poly-amine backbone. 3. Effect of replacing the inner polymethylene chain with cyclic moieties. J Med Chem 47 (26):6490-6498
44. Tumiatti V, Milelli A, Minarini A, Rosini M, Bolognesi ML, Micco M, Andrisano V, Bartolini M, Mancini F, Recanatini M, Cavalli A, Melchiorre C (2008) Structure-activity relationships of acetylcholinesterase noncovalent inhibitors based on a poly-amine backbone. 4. Further investigation on the inner spacer. J Med Chem 51 (22):7308-7312
45. Wallace HM, Niiranen K (2007) Polyamine analogues-an update. Amino acids 33 (2):261-265
46. Wess J, Blin N, Mutschler E, Bluml K (1995) Muscarinic acetylcho-line receptors: structural basis of ligand binding and G protein coupling. Life Sci 56 (11-12): 915-922
47. Zini M, Passariello CL, Gottardi D, Cetrullo S, Flamigni F, Pignatti C, Minarini A, Tumiatti V, Milelli A, Melchiorre C, Stefanelli C (2009) Cytotoxicity of methoctramine and methoctramine-related polyamines. Chem Biol Inter 181 (3):409-416